Choice

Diabetes and death

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7160.0 (Published 12 September 1998) Cite this as: BMJ 1998;317:0

This week the BMJ and the Lancet between them publish a series of papers from the UK Prospective Study Group that carry important messages on treating type 2 diabetes. These trials have included over 1000 patients, taken over a decade to complete, and cost millions of pounds. Painstakingly, the dozens of contributors, led by Robert Turner, have used first class research methods to answer important, everyday clinical questions “that have haunted diabetes researchers and clinicians for years (p 693).”

The world has over 100 million diabetics, and the number is predicted …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe